EUVIMEDEUVIMED entdecken
Multizentrische StudieBeobachtungsstudie

Incremental Value of Cardiac Myosin-Binding Protein C for the Early Diagnosis of Acute Myocardial Infarction

Pedro Lopez-Ayala, Jasper Boeddinghaus, Luca Koechlin, Paolo Bima, Jonas Glaeser, Carlos C Spagnuolo, Luca Crisanti, Oscar Miro, Francisco Javier Martín-Sánchez, Michael Christ, Karin Wildi, Simona Piazza und 14 weitere

JACC · 2025-12 · 86 (25) · 2616-2632

DOI: 10.1016/j.jacc.2025.09.008 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift JACC, 2025-12. Verfasst von Pedro Lopez-Ayala und 25 weiteren Autor:innen. Beteiligte Einrichtung: Cardiovascular Research Institute Basel (CRIB) and Clinic of Cardiology, University Hospital Basel, Department of Clinical Research, University of Ba…. Hauptthemen laut MEDLINE: Carrier Proteins, Myocardial Infarction, Non-ST Elevated Myocardial Infarction. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 37 Literaturangaben. Gefördert von: University Hospital Basel.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Cardiac myosin-binding protein C (cMyC) is a cardiac-specific sarcomeric protein with faster release kinetics compared with those of high-sensitivity cardiac troponin (hs-cTn). OBJECTIVES: The aim of this study was to compare the diagnostic performance of cMyC, measured with a novel prototype automated immunoassay, with high-sensitivity cardiac troponin T (hs-cTnT) and high-sensitivity cardiac troponin I (hs-cTnI) for the early diagnosis of non-ST-segment elevation myocardial infarction (NSTEMI). Furthermore, we derived a single blood draw dual-biomarker strategy combining hs-cTn and cMyC and compared it with the hs-cTnT/I-only strategy endorsed by the European Society of Cardiology. METHODS: This was a secondary analysis from an international prospective study recruiting adult patients presenting to the emergency department (ED) with suspected NSTEMI. cMyC, hs-cTnT, and hs-cTnI concentrations were measured upon ED presentation. Final diagnoses were centrally adjudicated by 2 independent cardiologists blinded to cMyC values. To compare the single- and dual-biomarker strategy, safety (defined as the sensitivity and negative predictive value for ruling out index NSTEMI) and triage efficacy (defined as the proportion of patients triaged to either rule-out or rule-in) were assessed. The diagnostic endpoint was index NSTEMI. The prognostic endpoint was 30-day, 1-year, and 5-year cardiovascular death or MI. Findings were externally validated in an independent international cohort. RESULTS: Among 4,735 eligible patients, 854 (18%) were diagnosed with NSTEMI. The discrimination for NSTEMI at presentation was higher for cMyC (area under the curve [AUC]: 0.943; 95% CI: 0.936-0.95) than for hs-cTnT (AUC: 0.936; 95% CI: 0.929-0.944; P = 0.008). Differences were mainly driven by patients with chest pain onset ≤3 hours (AUC of 0.939 [95% CI: 0.928-0.951] vs 0.921 [95% CI: 0.907-0.936], respectively; P < 0.001). The dual-biomarker strategy increased overall triage efficacy from 26.8% (hs-cTnT only) to 60.0% (hs-cTnT and cMyC), without compromising safety during the index visit. Despite identifying up to 3 times more patients for rule-out, the dual-biomarker strategy showed comparable cumulative incidences of cardiovascular death or myocardial infarction at 30 days, 1 year, and 5 years. Similar results were observed with hs-cTnI and in the external validation cohort. CONCLUSIONS: CMyC adds significant incremental value to hs-cTn values in the early diagnosis of NSTEMI, improving diagnostic discrimination and enabling more patients to be safely and immediately ruled out for NSTEMI. The single blood draw dual-biomarker strategy is particularly attractive in busy ED settings due to its simplicity and quick time-to-decision. (Advantageous Predictors of Acute Coronary Syndromes Evaluation [APACE]; NCT00470587).

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carrier ProteinsMyocardial InfarctionNon-ST Elevated Myocardial InfarctionAgedFemaleHumansMaleMiddle AgedBiomarkersEarly DiagnosisProspective StudiesTroponin ITroponin TMyosin Binding Protein C

Stichwörter der Autor:innen

cMyCmyocardial infarctiontroponin

Substanzen

BiomarkersCarrier ProteinsTroponin ITroponin TMyosin Binding Protein C

Autor:innen und Institutionen

  • Cardiovascular Research Institute Basel (CRIB) and Clinic of Cardiology, University Hospital Basel, Department of Clinical Research, University of Basel, Basel, Switzerland; GREAT network, Rome, Italy.
  • Cardiovascular Research Institute Basel (CRIB) and Clinic of Cardiology, University Hospital Basel, Department of Clinical Research, University of Basel, Basel, Switzerland; GREAT network, Rome, Italy; Department of Car…
  • Cardiovascular Research Institute Basel (CRIB) and Clinic of Cardiology, University Hospital Basel, Department of Clinical Research, University of Basel, Basel, Switzerland.
  • GREAT network, Rome, Italy; Emergency Department, Hospital Clinic, University of Barcelona, Barcelona, Spain.
  • GREAT network, Rome, Italy; Emergency Department, Hospital Clínico San Carlos, Madrid, Spain.
  • Department of Emergency Medicine, Luzerner Kantonsspital, Luzern, Switzerland.

Förderung

  • University Hospital Basel

Zitieren

APA

Lopez-Ayala, P., Boeddinghaus, J., Koechlin, L., Bima, P., Glaeser, J., Spagnuolo, C. C., Crisanti, L., Miro, O., Martín-Sánchez, F. J., Christ, M., Wildi, K., Piazza, S., Nestelberger, T., Gimenez, M. R., Gehrke, J., Formambuh, J., Kaplan, E., Hure, G., Breidthardt, T., …, & APACE and TRAPID-AMI investigators (2025). Incremental Value of Cardiac Myosin-Binding Protein C for the Early Diagnosis of Acute Myocardial Infarction. JACC, 86(25), 2616-2632. https://doi.org/10.1016/j.jacc.2025.09.008

Vancouver

Lopez-Ayala P, Boeddinghaus J, Koechlin L, Bima P, Glaeser J, Spagnuolo CC, et al. Incremental Value of Cardiac Myosin-Binding Protein C for the Early Diagnosis of Acute Myocardial Infarction. JACC. 2025;86(25):2616-2632. doi:10.1016/j.jacc.2025.09.008

BibTeX
@article{LopezAyala2025,
  author = {Lopez-Ayala, Pedro and Boeddinghaus, Jasper and Koechlin, Luca and Bima, Paolo and Glaeser, Jonas and Spagnuolo, Carlos C and Crisanti, Luca and Miro, Oscar and Martín-Sánchez, Francisco Javier and Christ, Michael and Wildi, Karin and Piazza, Simona and Nestelberger, Thomas and Gimenez, Maria Rubini and Gehrke, Juliane and Formambuh, Jude and Kaplan, Emel and Hure, Gabrielle and Breidthardt, Tobias and Giannitsis, Evangelos and Lindahl, Bertil and Marber, Michael and Mahfoud, Felix and Strebel, Ivo and Mueller, Christian and APACE and TRAPID-AMI investigators, APACE and TRAPID-AMI investigators},
  title = {Incremental Value of Cardiac Myosin-Binding Protein C for the Early Diagnosis of Acute Myocardial Infarction},
  journal = {JACC},
  year = {2025},
  volume = {86},
  number = {25},
  pages = {2616--2632},
  doi = {10.1016/j.jacc.2025.09.008}
}
Kostenlos starten →